Clinical trials
Recruiting Observational Multiple Sclerosis, Relapsing-Remitting trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heinrich-Heine University, Duesseldorf | 2 |
| University Hospital, Basel, Switzerland | 2 |
| Amsterdam UMC, location VUmc | 1 |
| Cedars-Sinai Medical Center | 1 |
| Ege University | 1 |
| Haukeland University Hospital | 1 |
| Hoffmann-La Roche | 1 |
| Sheffield Teaching Hospitals NHS Foundation Trust | 1 |
| University of Aarhus | 1 |
| University of California, San Francisco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 15 |
| Multiple Sclerosis | 10 |
| Multiple Sclerosis, Chronic Progressive | 5 |
| Fatigue | 2 |
| Anxiety Disorders | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| Cognitive Dysfunction | 1 |
| Fatigue Syndrome, Chronic | 1 |
| Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | 1 |
| Nervous System Diseases | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.